1 Bouchardy J, Prêtre R. Cardiopathies congénitales: prise en charge du patient adulte. Swiss Med Forum. 2014;14(15):311–3.
2. Dolk H, Loane M, Garne E, European Surveillance of Congenital Anomalies (EUROCAT) Working Group. Congenital heart defects in Europe: prevalence and perinatal mortality, 2000 to 2005. Circulation. 2011;123(8):841–9.
3. Bernier P-L, Stefanescu A, Samoukovic G, Tchervenkov CI. The challenge of congenital heart disease worldwide: epidemiologic and demographic facts. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu. 2010;13(1):26–34.
4. van der Bom T, Zomer AC, Zwinderman AH, Meijboom FJ, Bouma BJ, Mulder BJM. The changing epidemiology of congenital heart disease. Nat Rev Cardiol. 2011;8(1):50–60.
5. Nora JJ. Multifactorial inheritance hypothesis for the etiology of congenital heart diseases. The genetic-environmental interaction. Circulation. 1968;38(3):604–17.
6. Ferencz C, Rubin JD, McCarter RJ, Brenner JI, Neill CA, Perry LW, et al. Congenital heart disease: prevalence at livebirth. The Baltimore-Washington Infant Study. Am J Epidemiol. 1985;121(1):
31–6.
7. Wolf M, Basson CT. The molecular genetics of congenital heart disease: a review of recent developments. Curr Opin Cardiol. 2010;25(3):192–7.
8. Brickner ME, Hillis LD, Lange RA. Congenital heart disease in adults. First of two parts. N Engl J Med. 2000;342(4):256–63.
9. Brickner ME, Hillis LD, Lange RA. Congenital heart disease in adults. Second of two parts. N Engl J Med. 2000;342(5):334–42.
10. van der Linde D, Konings EEM, Slager MA, Witsenburg M, Helbing WA, Takkenberg JJM, et al. Birth prevalence of congenital heart disease worldwide: a systematic review and meta-analysis.
J Am Coll Cardiol. 2011;58(21):2241–7.
11. De Castro S, Cartoni D, Fiorelli M, Rasura M, Beni S, Urani C, Papetti F, Fedele F. Patent foramen ovale and its embolic implications.
Am J Cardiol. 2000;86(4A):51G–52G.
12. Schrale RG, Mitchell ARJ, Ormerod OJ. Patent foramen ovale and the risk of cryptogenic stroke. J Am Coll Cardiol. 2006;48(9):1913–1914; author reply 1914.
13. Meier B, Kalesan B, Mattle HP, Khattab AA, Hildick-Smith D, Dudek D, et al. Percutaneous closure of patent foramen ovale in cryptogenic embolism. N Engl J Med. 2013;368(12):1083–91.
14. Küchler R, Meyer BJ. Fermeture du foramen ovale perméable – des éloges aux reproches? Swiss Med Forum. 2012;12(27–28):569–71.
15. Knirsch W, Nadal D. Infective endocarditis in congenital heart disease. Eur J Pediatr. 2011;170(9):1111–27.
16. Habib G, Lancellotti P, Antunes MJ, Bongiorni MG, Casalta J-P, Del Zotti F, et al. 2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur Heart J. 2015;36(44):3075–128.
17. Flückiger U, Andres J. Revidierte schweizerische Richtlinien für die Endokarditis-Prophylaxe. 2009;11(12):392–400.
18. T Takken AG. Recommendations for physical activity, recreation sport, and exercise training in paediatric patients with congenital heart disease: a report from the Exercise, Basic & Translational Research Section of the European Association of Cardiovascular Prevention and Rehabilitation, the European Congenital Heart and Lung Exercise Group, and the Association for European Paediatric Cardiology. Eur J Prev Cardiol. 2012;19(5):1034–65.
19. Ladouceur M, Iserin L, Cohen S, Legendre A, Boudjemline Y, Bonnet D. Key issues of daily life in adults with congenital heart disease. Arch Cardiovasc Dis. 2013;106(6–7):404–12.
20. Broberg CS, Uebing A, Cuomo L, Thein SL, Papadopoulos MG, Gatzoulis MA. Adult patients with Eisenmenger syndrome report flying safely on commercial airlines. Heart Br Card Soc. 2007;93(12):1599–603.
21. Rimoldi SF, Sartori C, Seiler C, Delacrétaz E, Mattle HP, Scherrer U, et al. High-altitude exposure in patients with cardiovascular disease: risk assessment and practical recommendations.
Prog Cardiovasc Dis. 2010;52(6):512–24.